A Randomized Controlled Trial Comparing Platelet-Rich Plasma, Low-Level Laser Therapy, and Complex Decongestive Physiotherapy in Patients with Lower Limb Lymphedema
LYMPHATIC RESEARCH AND BIOLOGY, vol.18, pp.439-447, 2020 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 18
- Publication Date: 2020
- Doi Number: 10.1089/lrb.2019.0064
- Journal Name: LYMPHATIC RESEARCH AND BIOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
- Page Numbers: pp.439-447
- Keywords: secondary lymphedema, platelet-rich plasma, low-level laser therapy, complex decongestive physiotherapy, QoL, MAST-CELLS, DEVICE, BLOOD, SKIN
- Open Archive Collection: Article
- Azerbaijan State University of Economics (UNEC) Affiliated: No
Abstract
Background: Platelet-rich plasma (PRP) is an autologous concentrated preparation of platelets characterized by lymphangiogenetic and tissue-repairing effects. Although PRP has been safely used in many different fields, there is no clinical study regarding the use of PRP in lymphedema treatment in humans. We assessed the clinical outcomes of PRP in patients with lower extremity lymphedema (LEL) in a randomized controlled trial.